1468 related articles for article (PubMed ID: 16181219)
1. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
2. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
3. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
4. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
[TBL] [Abstract][Full Text] [Related]
5. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
6. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
Seed CR; Kiely P; Keller AJ
Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
[TBL] [Abstract][Full Text] [Related]
7. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ
N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512
[TBL] [Abstract][Full Text] [Related]
8. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
[TBL] [Abstract][Full Text] [Related]
9. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
Shang G; Seed CR; Wang F; Nie D; Farrugia A
Transfusion; 2007 Mar; 47(3):529-39. PubMed ID: 17319836
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
[TBL] [Abstract][Full Text] [Related]
11. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
[TBL] [Abstract][Full Text] [Related]
12. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
[TBL] [Abstract][Full Text] [Related]
13. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
Zou S; Dodd RY; Stramer SL; Strong DM;
N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
[TBL] [Abstract][Full Text] [Related]
15. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Fearon MA; Allain JP
Vox Sang; 2012 Jul; 103(1):83-6. PubMed ID: 22289147
[TBL] [Abstract][Full Text] [Related]
16. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
17. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.
Offergeld R; Faensen D; Ritter S; Hamouda O
Euro Surveill; 2005 Feb; 10(2):8-11. PubMed ID: 15735310
[TBL] [Abstract][Full Text] [Related]
19. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.
Busch MP; Glynn SA; Stramer SL; Strong DM; Caglioti S; Wright DJ; Pappalardo B; Kleinman SH;
Transfusion; 2005 Feb; 45(2):254-64. PubMed ID: 15660836
[TBL] [Abstract][Full Text] [Related]
20. Residual risk of HIV, HVB and HCV transmission by blood transfusion between 2002 and 2004 at the Abidjan National Blood Transfusion Center.
Ouattara H; Siransy-Bogui L; Fretz C; Diane KM; Konate S; Koidio A; Minga KA; Hyda J; Koffi-Abe N; Offoumou AM; Abissey S
Transfus Clin Biol; 2006 Oct; 13(4):242-5. PubMed ID: 16822686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]